Global and Japan HER-2 Targeted Drugs for Breast Cancer Market Size, Status and Forecast 2021-2027

Global and Japan HER-2 Targeted Drugs for Breast Cancer Market Size, Status and Forecast 2021-2027

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global HER-2 Targeted Drugs for Breast Cancer Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Trastuzumab
1.2.3 Pertuzumab
1.2.4 Lapatinib
1.2.5 Neratinib
1.2.6 Trastuzumab Emtansine
1.2.7 Pyrotinib
1.2.8 Other
1.3 Market by Application
1.3.1 Global HER-2 Targeted Drugs for Breast Cancer Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Drug Center
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global HER-2 Targeted Drugs for Breast Cancer Market Perspective (2016-2027)
2.2 HER-2 Targeted Drugs for Breast Cancer Growth Trends by Regions
2.2.1 HER-2 Targeted Drugs for Breast Cancer Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 HER-2 Targeted Drugs for Breast Cancer Historic Market Share by Regions (2016-2021)
2.2.3 HER-2 Targeted Drugs for Breast Cancer Forecasted Market Size by Regions (2022-2027)
2.3 HER-2 Targeted Drugs for Breast Cancer Industry Dynamic
2.3.1 HER-2 Targeted Drugs for Breast Cancer Market Trends
2.3.2 HER-2 Targeted Drugs for Breast Cancer Market Drivers
2.3.3 HER-2 Targeted Drugs for Breast Cancer Market Challenges
2.3.4 HER-2 Targeted Drugs for Breast Cancer Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top HER-2 Targeted Drugs for Breast Cancer Players by Revenue
3.1.1 Global Top HER-2 Targeted Drugs for Breast Cancer Players by Revenue (2016-2021)
3.1.2 Global HER-2 Targeted Drugs for Breast Cancer Revenue Market Share by Players (2016-2021)
3.2 Global HER-2 Targeted Drugs for Breast Cancer Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by HER-2 Targeted Drugs for Breast Cancer Revenue
3.4 Global HER-2 Targeted Drugs for Breast Cancer Market Concentration Ratio
3.4.1 Global HER-2 Targeted Drugs for Breast Cancer Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by HER-2 Targeted Drugs for Breast Cancer Revenue in 2020
3.5 HER-2 Targeted Drugs for Breast Cancer Key Players Head office and Area Served
3.6 Key Players HER-2 Targeted Drugs for Breast Cancer Product Solution and Service
3.7 Date of Enter into HER-2 Targeted Drugs for Breast Cancer Market
3.8 Mergers & Acquisitions, Expansion Plans
4 HER-2 Targeted Drugs for Breast Cancer Breakdown Data by Type
4.1 Global HER-2 Targeted Drugs for Breast Cancer Historic Market Size by Type (2016-2021)
4.2 Global HER-2 Targeted Drugs for Breast Cancer Forecasted Market Size by Type (2022-2027)
5 HER-2 Targeted Drugs for Breast Cancer Breakdown Data by Application
5.1 Global HER-2 Targeted Drugs for Breast Cancer Historic Market Size by Application (2016-2021)
5.2 Global HER-2 Targeted Drugs for Breast Cancer Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America HER-2 Targeted Drugs for Breast Cancer Market Size (2016-2027)
6.2 North America HER-2 Targeted Drugs for Breast Cancer Market Size by Type
6.2.1 North America HER-2 Targeted Drugs for Breast Cancer Market Size by Type (2016-2021)
6.2.2 North America HER-2 Targeted Drugs for Breast Cancer Market Size by Type (2022-2027)
6.2.3 North America HER-2 Targeted Drugs for Breast Cancer Market Size by Type (2016-2027)
6.3 North America HER-2 Targeted Drugs for Breast Cancer Market Size by Application
6.3.1 North America HER-2 Targeted Drugs for Breast Cancer Market Size by Application (2016-2021)
6.3.2 North America HER-2 Targeted Drugs for Breast Cancer Market Size by Application (2022-2027)
6.3.3 North America HER-2 Targeted Drugs for Breast Cancer Market Size by Application (2016-2027)
6.4 North America HER-2 Targeted Drugs for Breast Cancer Market Size by Country
6.4.1 North America HER-2 Targeted Drugs for Breast Cancer Market Size by Country (2016-2021)
6.4.2 North America HER-2 Targeted Drugs for Breast Cancer Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe HER-2 Targeted Drugs for Breast Cancer Market Size (2016-2027)
7.2 Europe HER-2 Targeted Drugs for Breast Cancer Market Size by Type
7.2.1 Europe HER-2 Targeted Drugs for Breast Cancer Market Size by Type (2016-2021)
7.2.2 Europe HER-2 Targeted Drugs for Breast Cancer Market Size by Type (2022-2027)
7.2.3 Europe HER-2 Targeted Drugs for Breast Cancer Market Size by Type (2016-2027)
7.3 Europe HER-2 Targeted Drugs for Breast Cancer Market Size by Application
7.3.1 Europe HER-2 Targeted Drugs for Breast Cancer Market Size by Application (2016-2021)
7.3.2 Europe HER-2 Targeted Drugs for Breast Cancer Market Size by Application (2022-2027)
7.3.3 Europe HER-2 Targeted Drugs for Breast Cancer Market Size by Application (2016-2027)
7.4 Europe HER-2 Targeted Drugs for Breast Cancer Market Size by Country
7.4.1 Europe HER-2 Targeted Drugs for Breast Cancer Market Size by Country (2016-2021)
7.4.2 Europe HER-2 Targeted Drugs for Breast Cancer Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific HER-2 Targeted Drugs for Breast Cancer Market Size (2016-2027)
8.2 Asia-Pacific HER-2 Targeted Drugs for Breast Cancer Market Size by Type
8.2.1 Asia-Pacific HER-2 Targeted Drugs for Breast Cancer Market Size by Type (2016-2021)
8.2.2 Asia-Pacific HER-2 Targeted Drugs for Breast Cancer Market Size by Type (2022-2027)
8.2.3 Asia-Pacific HER-2 Targeted Drugs for Breast Cancer Market Size by Type (2016-2027)
8.3 Asia-Pacific HER-2 Targeted Drugs for Breast Cancer Market Size by Application
8.3.1 Asia-Pacific HER-2 Targeted Drugs for Breast Cancer Market Size by Application (2016-2021)
8.3.2 Asia-Pacific HER-2 Targeted Drugs for Breast Cancer Market Size by Application (2022-2027)
8.3.3 Asia-Pacific HER-2 Targeted Drugs for Breast Cancer Market Size by Application (2016-2027)
8.4 Asia-Pacific HER-2 Targeted Drugs for Breast Cancer Market Size by Region
8.4.1 Asia-Pacific HER-2 Targeted Drugs for Breast Cancer Market Size by Region (2016-2021)
8.4.2 Asia-Pacific HER-2 Targeted Drugs for Breast Cancer Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America HER-2 Targeted Drugs for Breast Cancer Market Size (2016-2027)
9.2 Latin America HER-2 Targeted Drugs for Breast Cancer Market Size by Type
9.2.1 Latin America HER-2 Targeted Drugs for Breast Cancer Market Size by Type (2016-2021)
9.2.2 Latin America HER-2 Targeted Drugs for Breast Cancer Market Size by Type (2022-2027)
9.2.3 Latin America HER-2 Targeted Drugs for Breast Cancer Market Size by Type (2016-2027)
9.3 Latin America HER-2 Targeted Drugs for Breast Cancer Market Size by Application
9.3.1 Latin America HER-2 Targeted Drugs for Breast Cancer Market Size by Application (2016-2021)
9.3.2 Latin America HER-2 Targeted Drugs for Breast Cancer Market Size by Application (2022-2027)
9.3.3 Latin America HER-2 Targeted Drugs for Breast Cancer Market Size by Application (2016-2027)
9.4 Latin America HER-2 Targeted Drugs for Breast Cancer Market Size by Country
9.4.1 Latin America HER-2 Targeted Drugs for Breast Cancer Market Size by Country (2016-2021)
9.4.2 Latin America HER-2 Targeted Drugs for Breast Cancer Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa HER-2 Targeted Drugs for Breast Cancer Market Size (2016-2027)
10.2 Middle East & Africa HER-2 Targeted Drugs for Breast Cancer Market Size by Type
10.2.1 Middle East & Africa HER-2 Targeted Drugs for Breast Cancer Market Size by Type (2016-2021)
10.2.2 Middle East & Africa HER-2 Targeted Drugs for Breast Cancer Market Size by Type (2022-2027)
10.2.3 Middle East & Africa HER-2 Targeted Drugs for Breast Cancer Market Size by Type (2016-2027)
10.3 Middle East & Africa HER-2 Targeted Drugs for Breast Cancer Market Size by Application
10.3.1 Middle East & Africa HER-2 Targeted Drugs for Breast Cancer Market Size by Application (2016-2021)
10.3.2 Middle East & Africa HER-2 Targeted Drugs for Breast Cancer Market Size by Application (2022-2027)
10.3.3 Middle East & Africa HER-2 Targeted Drugs for Breast Cancer Market Size by Application (2016-2027)
10.4 Middle East & Africa HER-2 Targeted Drugs for Breast Cancer Market Size by Country
10.4.1 Middle East & Africa HER-2 Targeted Drugs for Breast Cancer Market Size by Country (2016-2021)
10.4.2 Middle East & Africa HER-2 Targeted Drugs for Breast Cancer Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Details
11.1.2 Roche Business Overview
11.1.3 Roche HER-2 Targeted Drugs for Breast Cancer Introduction
11.1.4 Roche Revenue in HER-2 Targeted Drugs for Breast Cancer Business (2016-2021)
11.1.5 Roche Recent Development
11.2 Chugai Pharmaceutical
11.2.1 Chugai Pharmaceutical Company Details
11.2.2 Chugai Pharmaceutical Business Overview
11.2.3 Chugai Pharmaceutical HER-2 Targeted Drugs for Breast Cancer Introduction
11.2.4 Chugai Pharmaceutical Revenue in HER-2 Targeted Drugs for Breast Cancer Business (2016-2021)
11.2.5 Chugai Pharmaceutical Recent Development
11.3 GlaxoSmithKline
11.3.1 GlaxoSmithKline Company Details
11.3.2 GlaxoSmithKline Business Overview
11.3.3 GlaxoSmithKline HER-2 Targeted Drugs for Breast Cancer Introduction
11.3.4 GlaxoSmithKline Revenue in HER-2 Targeted Drugs for Breast Cancer Business (2016-2021)
11.3.5 GlaxoSmithKline Recent Development
11.4 Novartis
11.4.1 Novartis Company Details
11.4.2 Novartis Business Overview
11.4.3 Novartis HER-2 Targeted Drugs for Breast Cancer Introduction
11.4.4 Novartis Revenue in HER-2 Targeted Drugs for Breast Cancer Business (2016-2021)
11.4.5 Novartis Recent Development
11.5 Pfizer
11.5.1 Pfizer Company Details
11.5.2 Pfizer Business Overview
11.5.3 Pfizer HER-2 Targeted Drugs for Breast Cancer Introduction
11.5.4 Pfizer Revenue in HER-2 Targeted Drugs for Breast Cancer Business (2016-2021)
11.5.5 Pfizer Recent Development
11.6 CANbridge
11.6.1 CANbridge Company Details
11.6.2 CANbridge Business Overview
11.6.3 CANbridge HER-2 Targeted Drugs for Breast Cancer Introduction
11.6.4 CANbridge Revenue in HER-2 Targeted Drugs for Breast Cancer Business (2016-2021)
11.6.5 CANbridge Recent Development
11.7 Puma Biotechnology
11.7.1 Puma Biotechnology Company Details
11.7.2 Puma Biotechnology Business Overview
11.7.3 Puma Biotechnology HER-2 Targeted Drugs for Breast Cancer Introduction
11.7.4 Puma Biotechnology Revenue in HER-2 Targeted Drugs for Breast Cancer Business (2016-2021)
11.7.5 Puma Biotechnology Recent Development
11.8 Hengrui Medicine
11.8.1 Hengrui Medicine Company Details
11.8.2 Hengrui Medicine Business Overview
11.8.3 Hengrui Medicine HER-2 Targeted Drugs for Breast Cancer Introduction
11.8.4 Hengrui Medicine Revenue in HER-2 Targeted Drugs for Breast Cancer Business (2016-2021)
11.8.5 Hengrui Medicine Recent Development
11.9 Beacon Pharmaceuticals Limited
11.9.1 Beacon Pharmaceuticals Limited Company Details
11.9.2 Beacon Pharmaceuticals Limited Business Overview
11.9.3 Beacon Pharmaceuticals Limited HER-2 Targeted Drugs for Breast Cancer Introduction
11.9.4 Beacon Pharmaceuticals Limited Revenue in HER-2 Targeted Drugs for Breast Cancer Business (2016-2021)
11.9.5 Beacon Pharmaceuticals Limited Recent Development
11.10 Hetero Drugs 
11.10.1 Hetero Drugs  Company Details
11.10.2 Hetero Drugs  Business Overview
11.10.3 Hetero Drugs  HER-2 Targeted Drugs for Breast Cancer Introduction
11.10.4 Hetero Drugs  Revenue in HER-2 Targeted Drugs for Breast Cancer Business (2016-2021)
11.10.5 Hetero Drugs  Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global HER-2 Targeted Drugs for Breast Cancer Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Trastuzumab
Table 3. Key Players of Pertuzumab
Table 4. Key Players of Lapatinib
Table 5. Key Players of Neratinib
Table 6. Key Players of Trastuzumab Emtansine
Table 7. Key Players of Pyrotinib
Table 8. Key Players of Other
Table 9. Global HER-2 Targeted Drugs for Breast Cancer Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 10. Global HER-2 Targeted Drugs for Breast Cancer Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 11. Global HER-2 Targeted Drugs for Breast Cancer Market Size by Regions (2016-2021) & (US$ Million)
Table 12. Global HER-2 Targeted Drugs for Breast Cancer Market Share by Regions (2016-2021)
Table 13. Global HER-2 Targeted Drugs for Breast Cancer Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 14. Global HER-2 Targeted Drugs for Breast Cancer Market Share by Regions (2022-2027)
Table 15. HER-2 Targeted Drugs for Breast Cancer Market Trends
Table 16. HER-2 Targeted Drugs for Breast Cancer Market Drivers
Table 17. HER-2 Targeted Drugs for Breast Cancer Market Challenges
Table 18. HER-2 Targeted Drugs for Breast Cancer Market Restraints
Table 19. Global HER-2 Targeted Drugs for Breast Cancer Revenue by Players (2016-2021) & (US$ Million)
Table 20. Global HER-2 Targeted Drugs for Breast Cancer Market Share by Players (2016-2021)
Table 21. Global Top HER-2 Targeted Drugs for Breast Cancer Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in HER-2 Targeted Drugs for Breast Cancer as of 2020)
Table 22. Ranking of Global Top HER-2 Targeted Drugs for Breast Cancer Companies by Revenue (US$ Million) in 2020
Table 23. Global 5 Largest Players Market Share by HER-2 Targeted Drugs for Breast Cancer Revenue (CR5 and HHI) & (2016-2021)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players HER-2 Targeted Drugs for Breast Cancer Product Solution and Service
Table 26. Date of Enter into HER-2 Targeted Drugs for Breast Cancer Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global HER-2 Targeted Drugs for Breast Cancer Market Size by Type (2016-2021) (US$ Million)
Table 29. Global HER-2 Targeted Drugs for Breast Cancer Revenue Market Share by Type (2016-2021)
Table 30. Global HER-2 Targeted Drugs for Breast Cancer Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 31. Global HER-2 Targeted Drugs for Breast Cancer Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 32. Global HER-2 Targeted Drugs for Breast Cancer Market Size Share by Application (2016-2021) & (US$ Million)
Table 33. Global HER-2 Targeted Drugs for Breast Cancer Revenue Market Share by Application (2016-2021)
Table 34. Global HER-2 Targeted Drugs for Breast Cancer Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 35. Global HER-2 Targeted Drugs for Breast Cancer Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 36. North America HER-2 Targeted Drugs for Breast Cancer Market Size by Type (2016-2021) (US$ Million)
Table 37. North America HER-2 Targeted Drugs for Breast Cancer Market Size by Type (2022-2027) & (US$ Million)
Table 38. North America HER-2 Targeted Drugs for Breast Cancer Market Size by Application (2016-2021) (US$ Million)
Table 39. North America HER-2 Targeted Drugs for Breast Cancer Market Size by Application (2022-2027) & (US$ Million)
Table 40. North America HER-2 Targeted Drugs for Breast Cancer Market Size by Country (2016-2021) & (US$ Million)
Table 41. North America HER-2 Targeted Drugs for Breast Cancer Market Size by Country (2022-2027) & (US$ Million)
Table 42. Europe HER-2 Targeted Drugs for Breast Cancer Market Size by Type (2016-2021) (US$ Million)
Table 43. Europe HER-2 Targeted Drugs for Breast Cancer Market Size by Type (2022-2027) & (US$ Million)
Table 44. Europe HER-2 Targeted Drugs for Breast Cancer Market Size by Application (2016-2021) (US$ Million)
Table 45. Europe HER-2 Targeted Drugs for Breast Cancer Market Size by Application (2022-2027) & (US$ Million)
Table 46. Europe HER-2 Targeted Drugs for Breast Cancer Market Size by Country (2016-2021) & (US$ Million)
Table 47. Europe HER-2 Targeted Drugs for Breast Cancer Market Size by Country (2022-2027) & (US$ Million)
Table 48. Asia-Pacific HER-2 Targeted Drugs for Breast Cancer Market Size by Type (2016-2021) (US$ Million)
Table 49. Asia-Pacific HER-2 Targeted Drugs for Breast Cancer Market Size by Type (2022-2027) & (US$ Million)
Table 50. Asia-Pacific HER-2 Targeted Drugs for Breast Cancer Market Size by Application (2016-2021) (US$ Million)
Table 51. Asia-Pacific HER-2 Targeted Drugs for Breast Cancer Market Size by Application (2022-2027) & (US$ Million)
Table 52. Asia-Pacific HER-2 Targeted Drugs for Breast Cancer Market Size by Region (2016-2021) & (US$ Million)
Table 53. Asia-Pacific HER-2 Targeted Drugs for Breast Cancer Market Size by Region (2022-2027) & (US$ Million)
Table 54. Latin America HER-2 Targeted Drugs for Breast Cancer Market Size by Type (2016-2021) (US$ Million)
Table 55. Latin America HER-2 Targeted Drugs for Breast Cancer Market Size by Type (2022-2027) & (US$ Million)
Table 56. Latin America HER-2 Targeted Drugs for Breast Cancer Market Size by Application (2016-2021) (US$ Million)
Table 57. Latin America HER-2 Targeted Drugs for Breast Cancer Market Size by Application (2022-2027) & (US$ Million)
Table 58. Latin America HER-2 Targeted Drugs for Breast Cancer Market Size by Country (2016-2021) & (US$ Million)
Table 59. Latin America HER-2 Targeted Drugs for Breast Cancer Market Size by Country (2022-2027) & (US$ Million)
Table 60. Middle East & Africa HER-2 Targeted Drugs for Breast Cancer Market Size by Type (2016-2021) (US$ Million)
Table 61. Middle East & Africa HER-2 Targeted Drugs for Breast Cancer Market Size by Type (2022-2027) & (US$ Million)
Table 62. Middle East & Africa HER-2 Targeted Drugs for Breast Cancer Market Size by Application (2016-2021) (US$ Million)
Table 63. Middle East & Africa HER-2 Targeted Drugs for Breast Cancer Market Size by Application (2022-2027) & (US$ Million)
Table 64. Middle East & Africa HER-2 Targeted Drugs for Breast Cancer Market Size by Country (2016-2021) & (US$ Million)
Table 65. Middle East & Africa HER-2 Targeted Drugs for Breast Cancer Market Size by Country (2022-2027) & (US$ Million)
Table 66. Roche Company Details
Table 67. Roche Business Overview
Table 68. Roche HER-2 Targeted Drugs for Breast Cancer Product
Table 69. Roche Revenue in HER-2 Targeted Drugs for Breast Cancer Business (2016-2021) & (US$ Million)
Table 70. Roche Recent Development
Table 71. Chugai Pharmaceutical Company Details
Table 72. Chugai Pharmaceutical Business Overview
Table 73. Chugai Pharmaceutical HER-2 Targeted Drugs for Breast Cancer Product
Table 74. Chugai Pharmaceutical Revenue in HER-2 Targeted Drugs for Breast Cancer Business (2016-2021) & (US$ Million)
Table 75. Chugai Pharmaceutical Recent Development
Table 76. GlaxoSmithKline Company Details
Table 77. GlaxoSmithKline Business Overview
Table 78. GlaxoSmithKline HER-2 Targeted Drugs for Breast Cancer Product
Table 79. GlaxoSmithKline Revenue in HER-2 Targeted Drugs for Breast Cancer Business (2016-2021) & (US$ Million)
Table 80. GlaxoSmithKline Recent Development
Table 81. Novartis Company Details
Table 82. Novartis Business Overview
Table 83. Novartis HER-2 Targeted Drugs for Breast Cancer Product
Table 84. Novartis Revenue in HER-2 Targeted Drugs for Breast Cancer Business (2016-2021) & (US$ Million)
Table 85. Novartis Recent Development
Table 86. Pfizer Company Details
Table 87. Pfizer Business Overview
Table 88. Pfizer HER-2 Targeted Drugs for Breast Cancer Product
Table 89. Pfizer Revenue in HER-2 Targeted Drugs for Breast Cancer Business (2016-2021) & (US$ Million)
Table 90. Pfizer Recent Development
Table 91. CANbridge Company Details
Table 92. CANbridge Business Overview
Table 93. CANbridge HER-2 Targeted Drugs for Breast Cancer Product
Table 94. CANbridge Revenue in HER-2 Targeted Drugs for Breast Cancer Business (2016-2021) & (US$ Million)
Table 95. CANbridge Recent Development
Table 96. Puma Biotechnology Company Details
Table 97. Puma Biotechnology Business Overview
Table 98. Puma Biotechnology HER-2 Targeted Drugs for Breast Cancer Product
Table 99. Puma Biotechnology Revenue in HER-2 Targeted Drugs for Breast Cancer Business (2016-2021) & (US$ Million)
Table 100. Puma Biotechnology Recent Development
Table 101. Hengrui Medicine Company Details
Table 102. Hengrui Medicine Business Overview
Table 103. Hengrui Medicine Revenue in HER-2 Targeted Drugs for Breast Cancer Business (2016-2021) & (US$ Million)
Table 104. Hengrui Medicine Recent Development
Table 105. Beacon Pharmaceuticals Limited Company Details
Table 106. Beacon Pharmaceuticals Limited Business Overview
Table 107. Beacon Pharmaceuticals Limited HER-2 Targeted Drugs for Breast Cancer Product
Table 108. Beacon Pharmaceuticals Limited Revenue in HER-2 Targeted Drugs for Breast Cancer Business (2016-2021) & (US$ Million)
Table 109. Beacon Pharmaceuticals Limited Recent Development
Table 110. Hetero Drugs  Company Details
Table 111. Hetero Drugs  Business Overview
Table 112. Hetero Drugs  HER-2 Targeted Drugs for Breast Cancer Product
Table 113. Hetero Drugs  Revenue in HER-2 Targeted Drugs for Breast Cancer Business (2016-2021) & (US$ Million)
Table 114. Hetero Drugs  Recent Development
Table 115. Research Programs/Design for This Report
Table 116. Key Data Information from Secondary Sources
Table 117. Key Data Information from Primary Sources
List of Figures
Figure 1. Global HER-2 Targeted Drugs for Breast Cancer Market Share by Type: 2020 VS 2027
Figure 2. Trastuzumab Features
Figure 3. Pertuzumab Features
Figure 4. Lapatinib Features
Figure 5. Neratinib Features
Figure 6. Trastuzumab Emtansine Features
Figure 7. Pyrotinib Features
Figure 8. Other Features
Figure 9. Global HER-2 Targeted Drugs for Breast Cancer Market Share by Application: 2020 VS 2027
Figure 10. Hospital Case Studies
Figure 11. Clinic Case Studies
Figure 12. Drug Center Case Studies
Figure 13. Other Case Studies
Figure 14. HER-2 Targeted Drugs for Breast Cancer Report Years Considered
Figure 15. Global HER-2 Targeted Drugs for Breast Cancer Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 16. Global HER-2 Targeted Drugs for Breast Cancer Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 17. Global HER-2 Targeted Drugs for Breast Cancer Market Share by Regions: 2020 VS 2027
Figure 18. Global HER-2 Targeted Drugs for Breast Cancer Market Share by Regions (2022-2027)
Figure 19. Global HER-2 Targeted Drugs for Breast Cancer Market Share by Players in 2020
Figure 20. Global Top HER-2 Targeted Drugs for Breast Cancer Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in HER-2 Targeted Drugs for Breast Cancer as of 2020
Figure 21. The Top 10 and 5 Players Market Share by HER-2 Targeted Drugs for Breast Cancer Revenue in 2020
Figure 22. Global HER-2 Targeted Drugs for Breast Cancer Revenue Market Share by Type (2016-2021)
Figure 23. Global HER-2 Targeted Drugs for Breast Cancer Revenue Market Share by Type (2022-2027)
Figure 24. North America HER-2 Targeted Drugs for Breast Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. North America HER-2 Targeted Drugs for Breast Cancer Market Share by Type (2016-2027)
Figure 26. North America HER-2 Targeted Drugs for Breast Cancer Market Share by Application (2016-2027)
Figure 27. North America HER-2 Targeted Drugs for Breast Cancer Market Share by Country (2016-2027)
Figure 28. United States HER-2 Targeted Drugs for Breast Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Canada HER-2 Targeted Drugs for Breast Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Europe HER-2 Targeted Drugs for Breast Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Europe HER-2 Targeted Drugs for Breast Cancer Market Share by Type (2016-2027)
Figure 32. Europe HER-2 Targeted Drugs for Breast Cancer Market Share by Application (2016-2027)
Figure 33. Europe HER-2 Targeted Drugs for Breast Cancer Market Share by Country (2016-2027)
Figure 34. Germany HER-2 Targeted Drugs for Breast Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. France HER-2 Targeted Drugs for Breast Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. U.K. HER-2 Targeted Drugs for Breast Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Italy HER-2 Targeted Drugs for Breast Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Russia HER-2 Targeted Drugs for Breast Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Nordic HER-2 Targeted Drugs for Breast Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Asia-Pacific HER-2 Targeted Drugs for Breast Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Asia-Pacific HER-2 Targeted Drugs for Breast Cancer Market Share by Type (2016-2027)
Figure 42. Asia-Pacific HER-2 Targeted Drugs for Breast Cancer Market Share by Application (2016-2027)
Figure 43. Asia-Pacific HER-2 Targeted Drugs for Breast Cancer Market Share by Region (2016-2027)
Figure 44. China HER-2 Targeted Drugs for Breast Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Japan HER-2 Targeted Drugs for Breast Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. South Korea HER-2 Targeted Drugs for Breast Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Southeast Asia HER-2 Targeted Drugs for Breast Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. India HER-2 Targeted Drugs for Breast Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Australia HER-2 Targeted Drugs for Breast Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Latin America HER-2 Targeted Drugs for Breast Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Latin America HER-2 Targeted Drugs for Breast Cancer Market Share by Type (2016-2027)
Figure 52. Latin America HER-2 Targeted Drugs for Breast Cancer Market Share by Application (2016-2027)
Figure 53. Latin America HER-2 Targeted Drugs for Breast Cancer Market Share by Country (2016-2027)
Figure 54. Mexico HER-2 Targeted Drugs for Breast Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Brazil HER-2 Targeted Drugs for Breast Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Middle East & Africa HER-2 Targeted Drugs for Breast Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Middle East & Africa HER-2 Targeted Drugs for Breast Cancer Market Share by Type (2016-2027)
Figure 58. Middle East & Africa HER-2 Targeted Drugs for Breast Cancer Market Share by Application (2016-2027)
Figure 59. Middle East & Africa HER-2 Targeted Drugs for Breast Cancer Market Share by Country (2016-2027)
Figure 60. Turkey HER-2 Targeted Drugs for Breast Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. Saudi Arabia HER-2 Targeted Drugs for Breast Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 62. UAE HER-2 Targeted Drugs for Breast Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 63. Roche Revenue Growth Rate in HER-2 Targeted Drugs for Breast Cancer Business (2016-2021)
Figure 64. Chugai Pharmaceutical Revenue Growth Rate in HER-2 Targeted Drugs for Breast Cancer Business (2016-2021)
Figure 65. GlaxoSmithKline Revenue Growth Rate in HER-2 Targeted Drugs for Breast Cancer Business (2016-2021)
Figure 66. Novartis Revenue Growth Rate in HER-2 Targeted Drugs for Breast Cancer Business (2016-2021)
Figure 67. Pfizer Revenue Growth Rate in HER-2 Targeted Drugs for Breast Cancer Business (2016-2021)
Figure 68. CANbridge Revenue Growth Rate in HER-2 Targeted Drugs for Breast Cancer Business (2016-2021)
Figure 69. Puma Biotechnology Revenue Growth Rate in HER-2 Targeted Drugs for Breast Cancer Business (2016-2021)
Figure 70. Hengrui Medicine Revenue Growth Rate in HER-2 Targeted Drugs for Breast Cancer Business (2016-2021)
Figure 71. Beacon Pharmaceuticals Limited Revenue Growth Rate in HER-2 Targeted Drugs for Breast Cancer Business (2016-2021)
Figure 72. Hetero Drugs  Revenue Growth Rate in HER-2 Targeted Drugs for Breast Cancer Business (2016-2021)
Figure 73. Bottom-up and Top-down Approaches for This Report
Figure 74. Data Triangulation
Figure 75. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029

Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118

The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......

Global Non-imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95

The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90

The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......

Global PCR Equipment Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77

The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......

Global Disposable Sterile Syringes and Needles Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109

The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......

Global Orthopaedic Power Tools Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......

Global Cerebrospinal Fluid Management Devices Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......

Global CAD & CAM Milling Burs Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79

The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......

Global Artificial Teeth Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98

The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs